Dr Lal Pathlabs Ltd vs Metropolis Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 03, 2026

Key Highlights

The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 1569 as of 03 Jun 15:30 . The P/E Ratio of Dr Lal Pathlabs Ltd changed from 77.4 on March 2021 to 42.5 on March 2025 . This represents a CAGR of -11.30% over 5 yearsThe P/E Ratio of Metropolis Healthcare Ltd changed from 62.6 on March 2021 to 55.8 on March 2025 . This represents a CAGR of -2.27% over 5 years The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 22565 crore on March 2021 to ₹ 20714 crore on March 2025 . This represents a CAGR of -1.70% over 5 yearsThe Market Cap of Metropolis Healthcare Ltd changed from ₹ 11455 crore on March 2021 to ₹ 8094 crore on March 2025 . This represents a CAGR of -6.71% over 5 years The revenue of Dr Lal Pathlabs Ltd for the Mar '26 is ₹ 726.7 crore as compare to the Dec '25 revenue of ₹ 684.2 crore. This represent the growth of 6.21% The revenue of Metropolis Healthcare Ltd for the Mar '26 is ₹ 432.95 crore as compare to the Dec '25 revenue of ₹ 414.93 crore. This represent the growth of 4.34% The ebitda of Dr Lal Pathlabs Ltd for the Mar '26 is ₹ 210.8 crore as compare to the Dec '25 ebitda of ₹ 173.6 crore. This represent the growth of 21.43% The ebitda of Metropolis Healthcare Ltd for the Mar '26 is ₹ 116.29 crore as compare to the Dec '25 ebitda of ₹ 94.77 crore. This represent the growth of 22.71% The net profit of Dr Lal Pathlabs Ltd changed from ₹ 107.8 crore to ₹ 132.2 crore over 8 quarters. This represents a CAGR of 10.74% The net profit of Metropolis Healthcare Ltd changed from ₹ 38.11 crore to ₹ 50.96 crore over 8 quarters. This represents a CAGR of 15.64% The Dividend Payout of Dr Lal Pathlabs Ltd changed from 59.51 % on March 2021 to 40.34 % on March 2025 . This represents a CAGR of -7.48% over 5 yearsThe Dividend Payout of Metropolis Healthcare Ltd changed from 20.69 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Dr Lal Pathlabs Ltd

Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Metropolis Healthcare Ltd

Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners.
The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards.
In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah.
Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis.
On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr.

FAQs for the comparison of Dr Lal Pathlabs Ltd and Metropolis Healthcare Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or Metropolis Healthcare Ltd?

Market cap of Dr Lal Pathlabs Ltd is 26,302 Cr while Market cap of Metropolis Healthcare Ltd is 11,108 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and Metropolis Healthcare Ltd?

The stock performance of Dr Lal Pathlabs Ltd and Metropolis Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and Metropolis Healthcare Ltd?

As of June 3, 2026, the Dr Lal Pathlabs Ltd stock price is INR ₹1569.0. On the other hand, Metropolis Healthcare Ltd stock price is INR ₹535.8.

How do dividend payouts of Dr Lal Pathlabs Ltd and Metropolis Healthcare Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and Metropolis Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.